Sign up to save your podcasts
Or
Share Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous
In this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies of work done in the International Space Station, the potential of crystalline suspensions and future opportunities. To learn more about the PODD Conference, please visit PODDConference.com.
View all episodes
By Conference ForumIn this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies of work done in the International Space Station, the potential of crystalline suspensions and future opportunities. To learn more about the PODD Conference, please visit PODDConference.com.